VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brian Malloy who wrote (149)	1/7/2000 3:02:00 AM
From: Manfred Sondermann	Read Replies (1) of 250

See: messages.yahoo.com >>The Prudential reports are free to download until the end of this >>Jan. >> >>The change of the earlier price of $36 (or$38) down to $21 was >>simply caused by share dilution [2.174 million]coincident with the >>private placement to Paul Allen's Vulcan ventures. VaxGen raised >>$25 million. PRU's October 14, Report states that as the only >>reason. They didn't lower their expectations at all. The change was >>treated as an adjusted target not as a lower target. I submit that >>Prudential has in reality upped their "adjusted" price target since >>publishing their first projection.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next